What is the average price of churna exports from India?

The average unit price for churna exports from India is $19.75 USD per unit, with prices ranging from $0.01 to $14293.30 depending on formulation, packaging, and order volume. The total market is valued at $1.8M across 4,397 shipments.

Which ports handle churna exports from India?

The primary ports for churna exports from India are COCHIN SEA (INCOK1) (12.8% of shipments), COCHIN SEA (10.5% of shipments), TUTICORIN SEA (INTUT1) (6.3% of shipments), TUTICORIN SEA (6.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Why is India a leading exporter of churna?

India is one of the world's leading exporters of churna due to its large base of 262 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports churna to 71 countries, demonstrating 36% global market coverage.

What certifications do Indian churna exporters need?

Indian churna exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

How many buyers import churna from India?

There are 473 registered buyers importing churna from India, spread across 71 countries. The repeat buyer rate is 67.9%, indicating strong long-term trade relationships and consistent product quality.

What is the market share of the top churna supplier from India?

SHETH BROTHERS is the leading churna exporter from India with a market share of 12.5% and total export value of $223.6K across 8 shipments. The top 5 suppliers together control 43.9% of total export value.

Churna

India Pharmaceutical Trade Intelligence

$1.8M262 Suppliers71 CountriesHS 30049011

ExportsIndia → UNITED ARAB32.1%India → NEPAL19.6%

Churna Export Data from India (2026) — Suppliers, Buyers & Trade Stats | TransData Nexus | TransData Nexus

How India Exports Churna to the World

Q: Who are the top churna exporters from India?

The top churna exporters from India are: 1. SHETH BROTHERS — $223.6K (12.5% market share); 2. BHUDARBHAI KARSHANDAS GANDHI — $169.6K (9.5% market share); 3. GREENSHIP EXPORTS — $146.1K (8.2% market share); 4. EMAMI LIMITED — $135.5K (7.6% market share); 5. DABUR INDIA LIMITED — $111.2K (6.2% market share). Together they account for 43.9% of India's total churna export value.

Q: What is the total export value of churna from India?

The total export value of churna from India is $1.8M USD, recorded across 4,397 shipment transactions from 262 active exporters to 71 destination countries. The average shipment value is $408.

Q: Which countries import churna from India?

India exports churna to 71 countries worldwide. The top importing countries are: UNITED ARAB EMIRATES (32.1% share, $574.9K), NEPAL (19.6% share, $351.8K), UNITED STATES (8.4% share, $150.6K), GERMANY (5.5% share, $97.8K), SOUTH AFRICA (4.6% share, $82.7K). These five markets account for 70.2% of total export value.

Q: What is the HS code for churna exports from India?

The primary HS code for churna exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Between 2022 and 2026, India exported $1.8M worth of churna across 4,397 verified shipments to 71 countries — covering 36% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is UNITED ARAB EMIRATES (32.1%). SHETH BROTHERS leads with a 12.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Churna export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Churna export data snapshot — $1.8M · 262 exporters · 71 countriesTransData Nexus · Indian Customs Data

Top Churna Exporters from India

262 active exporters · Ranked by export value

View all 262 →

Top Churna Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SHETH BROTHERS	$223.6K	8	2	12.5%
2	BHUDARBHAI KARSHANDAS GANDHI

Top Countries Importing Churna from India

71 destination markets · Ranked by import value

All 71 countries →

Top Countries Importing Churna from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED ARAB EMIRATES	$574.9K	32.1%
2	NEPAL	$351.8K	19.6%
3	UNITED STATES	$150.6K	8.4%
4	GERMANY	$97.8K	5.5%
5	SOUTH AFRICA	$82.7K	4.6%
6	CANADA	$71.7K	4.0%
7	AUSTRALIA	$64.8K	3.6%
8	RUSSIA	$55.2K	3.1%
9	UNITED KINGDOM	$48.1K	2.7%
10	TANZANIA	$42.8K	2.4%

UNITED ARAB EMIRATES is India's largest churna export destination, absorbing 32.1% of total exports worth $574.9K. The top 5 importing countries — UNITED ARAB EMIRATES, NEPAL, UNITED STATES, GERMANY, SOUTH AFRICA — together account for 70.2% of India's total churna export value. The remaining 66 destination countries collectively receive the other 29.8%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Churna

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, "Churna," classified under HS Code 30049011, is an Ayurvedic medicinal product traditionally used in India. The FDA's Orange Book, which lists approved drug products, does not include any entries for "Churna" or similar Ayurvedic formulations. Consequently, there are no approved Abbreviated New Drug Applications (ANDAs) for "Churna" in the United States. This absence indicates that "Churna" has not undergone the FDA's rigorous approval process required for marketing pharmaceutical products in the U.S.

Despite the lack of FDA approval, the United States accounted for 8.4% of "Churna" exports from India between 2022 and 2026, highlighting a demand within the U.S. market. However, without FDA approval, "Churna" cannot be legally marketed as a drug in the U.S. Importers and distributors must navigate complex regulatory pathways, potentially classifying "Churna" as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994. This classification requires adherence to specific labeling and marketing regulations, including the prohibition of disease-related claims.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, "Churna" falls under the category of traditional herbal medicinal products. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require such products to obtain a Traditional Herbal Registration (THR) before marketing. This process involves demonstrating safety and traditional use over a period of at least 30 years, including 15 years within the EU.

Compliance with Good Manufacturing Practice (GMP) standards is mandatory for all medicinal products in the EU and UK. Manufacturers exporting "Churna" to these markets must ensure their facilities meet EU GMP requirements, which are enforced through regular inspections. Failure to comply can result in import restrictions or product recalls.

3WHO Essential Medicines & Global Standards

"Churna" is not listed in the World Health Organization's (WHO) Model List of Essential Medicines, which primarily includes allopathic medicines. Consequently, it has not undergone the WHO Prequalification Programme, designed to ensure the quality, safety, and efficacy of medicinal products.

Regarding pharmacopoeial standards, "Churna" formulations are typically described in the Ayurvedic Pharmacopoeia of India (API). However, they are not included in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), or European Pharmacopoeia (EP). This exclusion may pose challenges for exporters, as compliance with these pharmacopoeias is often a prerequisite for market entry in various countries.

4India Regulatory Classification

In India, "Churna" is classified as an Ayurvedic medicine and is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940. It does not fall under Schedules H, H1, or X, which pertain to allopathic prescription drugs, nor is it classified as an over-the-counter (OTC) allopathic medicine.

The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of scheduled formulations under the Drugs (Prices Control) Order (DPCO), 2013. As of March 2025, the NPPA had fixed ceiling prices for 928 scheduled formulations. However, Ayurvedic medicines like "Churna" are generally not included in these price controls, allowing manufacturers greater flexibility in pricing.

For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the CDSCO, ensuring that the product complies with the regulatory requirements of the importing country. This process involves providing detailed product information, including composition, manufacturing process, and quality control measures.

5Patent & Exclusivity Status

"Churna" formulations, being traditional Ayurvedic preparations, are generally not subject to patent protection. This lack of exclusivity allows multiple manufacturers to produce and market "Churna" without infringing on intellectual property rights. Consequently, the market is characterized by significant generic competition, both domestically and internationally.

6Recent Industry Developments

In November 2025, the NPPA revised the ceiling prices of several key medicines under the DPCO, 2013. While this revision primarily affected allopathic medicines, it underscores the Indian government's ongoing efforts to regulate drug prices and ensure affordability.

In December 2025, the NPPA fixed the retail prices of 37 new drug formulations, covering a wide range of commonly used medicines, including those for hypertension, diabetes, respiratory disorders, allergies, and mental health conditions. This action reflects the authority's commitment to controlling drug prices and ensuring access to essential medicines.

These developments highlight the dynamic nature of pharmaceutical regulation in India, which can indirectly impact the Ayurvedic medicine sector by influencing market dynamics and pricing strategies.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Churna

Retail & reference prices across 9 markets vs. India FOB export price of $19.75/unit

Global Price Benchmark for Churna across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Ayurvedic products are not regulated by the FDA as drugs but as dietary supplements, leading to variability in pricing and availability.
United Kingdom	N/A	GBP	The UK's Medicines and Healthcare products Regulatory Agency (MHRA) does not provide standardized pricing for Ayurvedic supplements.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not list Ayurvedic products like Churna in its standard pharmaceutical pricing references.
Australia

Supply Chain Risk Assessment — Churna

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Churna, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of India's API requirements are fulfilled by Chinese manufacturers, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as any disruption in Chinese production or export policies can lead to shortages and price volatility in the Indian market.

The COVID-19 pandemic underscored these risks when Chinese factory shutdowns led to immediate scarcities of essential APIs and KSMs, causing price surges for common medications. Recognizing this, the Indian government initiated the Production Linked Incentive (PLI) scheme in October 2024 to bolster domestic manufacturing of critical pharmaceutical ingredients. Two new plants were inaugurated under this scheme to produce Penicillin G, 6-APA, and Clavulanic Acid—key molecules in antibiotic production that had not been manufactured domestically for over two decades.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Churna from India account for 43.9% of the total export value, with SHETH BROTHERS leading at 12.5%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact the overall supply chain.

Access Complete Churna Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,397 transactions across 71 markets.

Request Demo View Pricing

Frequently Asked Questions — Churna Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top churna exporters from India?

The leading churna exporters from India are SHETH BROTHERS, BHUDARBHAI KARSHANDAS GANDHI, GREENSHIP EXPORTS, and 11 others. SHETH BROTHERS leads with 12.5% market share ($223.6K). The top 5 suppliers together control 43.9% of total export value.

What is the total export value of churna from India?

The total export value of churna from India is $1.8M, recorded across 4,397 shipments from 262 active exporters to 71 countries. The average shipment value is $408.

Which countries import churna from India?

India exports churna to 71 countries. The top importing countries are UNITED ARAB EMIRATES (32.1%), NEPAL (19.6%), UNITED STATES (8.4%), GERMANY (5.5%), SOUTH AFRICA (4.6%), which together account for 70.2% of total export value.

What is the HS code for churna exports from India?

The primary HS code for churna exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Churna

Churna

How India Exports Churna to the World

Top Churna Exporters from India

Top Countries Importing Churna from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Churna

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Churna

Supply Chain Risk Assessment — Churna

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Churna Trade Intelligence

Frequently Asked Questions — Churna Exports from India

Who are the top churna exporters from India?

What is the total export value of churna from India?

Which countries import churna from India?

What is the HS code for churna exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of churna exports from India?

Which ports handle churna exports from India?

Why is India a leading exporter of churna?

What certifications do Indian churna exporters need?

How many buyers import churna from India?

What is the market share of the top churna exporter from India?

Analysis Methodology